Impact Analysis of Covid-19
The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Dysphagia Management Market – Insights
Dysphagia is characterized by difficulty in swallowing foods or liquids. Causes of the disease include, large bites of food, inadequate chewing, dry mouth, pills, or consumption of very hot food. Dysphagia management involves use of food texture altering products and other products such as tubes to ease the process of swallowing. Although there are some drugs for the treatment of dysphagia, not all the types of the diseases are treated using drugs.
The global dysphagia management market is estimated to account for US$ 5,040.7 Mn in terms of value by the end of 2027.
Global Dysphagia Management Market: Drivers
Increasing geriatric population is expected to propel growth of the global dysphagia management market over the forecast period. For instance, according to the U.S. Census Bureau, geriatric population in the U.S. is expected to reach 77 million by 2035.
Moreover, increasing number of people addicted to smoking is also expected to aid in growth of the market. For instance, according to the World Health Organization, 1.337 billion people smoked tobacco worldwide in 2018.
North America region held dominant position in the global dysphagia management market in 2019, accounting for 36.1% share in terms of volume, followed by Europe.
Figure 1. Global Dysphagia Management Market Share (%), by Region, 2019
Source: Coherent Market Insights Analysis (2020)
Global Dysphagia Management Market: Restraints
Side effects and discomfort of dysphagia drugs and tubes are expected to hamper growth of the market. Long-term use of dysphagia drugs such as proton pump inhibitors is associated with certain threats such as increased risk of hip bone fracture due to decreased absorption of calcium and iron and risk of opportunistic infections with S. pneumonia and C. defficile owing to diminished natural gut flora. Moreover, use of nasogastric tubes or PEG tubes may lead to irritation to the throat, abdominal cramping, abdominal swelling, diarrhea, nausea, vomiting, and regurgitation of food and medicines.
Moreover, difficulty in diagnosis of the exact cause of dysphagia is expected to limit growth of the market. There are many causes for dysphagia, and in some cases, it is difficult to establish the etiology of the disease.
Global Dysphagia Management Market: Opportunities
Market players can focus on launching OTC drugs for the treatment of dysphagia. For instance, majority of pharmaceutical companies in Western Europe such as Bayer AG and Johnson & Johnson are expanding into to OTC business as a contiguous out-of-pocket market.
Moreover, development of standard definitions of dysphagia and malnutrition, in-depth assessment of link between causes and outcome of dysphagia, and importance on the need for efficient and accurate screening is also expected to aid in growth of the market.
Drugs segment in the global dysphagia management market was valued at US$ 268.9 Mn in 2019 and is expected to reach US$ 403.7 Mn by 2027 at a CAGR of 5.2% during the forecast period.
Market Trends/Key Takeaways
Lack of advanced therapies for dysphagia and low awareness of the disease are major issues in developing countries. In developing countries such as India, South Africa, and Mexico, patients find difficulties procuring nutritional solutions used in the management of dysphagia. Moreover, several patient remain undiagnosed due to lack of robust medical facilities in these countries.
The prevalence of dysphagia in patients suffering from unilateral vocal fold immobility is high. For instance, according to June 2019 study in the journal Otolaryngology–Head and Neck, the prevalence of symptomatic dysphagia ranged from 55.6% to 69.0% and the aspiration rate was 20.0% to 50.0% in patients suffering from unilateral vocal fold immobility.
Global Dysphagia Management Market: Competitive Landscape
Major players operating in the global dysphagia management market include, Eisai Co. Ltd., C. R. Bard, Inc. (Becton, Dickinson and Company), Hormel Health Labs, AstraZeneca, Cipla Ltd., Nestlé Health Science, Kent Precision Foods Group, Inc., Bracco Diagnostics Inc., Phagenesis Ltd., Nutricia Advanced Medical Nutrition, and Cook Medical Inc.
Global Dysphagia Management Market: Key Developments
Major players in the market are focused on approval and launch of new products to expand their product portfolio. For instance, in January 2020, Phagenesis Ltd. received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for its Phagenyx System used for the treatment of neurogenic dysphagia.
In July 2019, Hormel Health Labs, a manufacturer of health and nutrition products, launched Thick & Easy Coffee Sticks, for people suffering from dysphagia.